Allergen immunotherapy with cat allergen peptides

Springer Seminars in Immunopathology

Volumn 25, Issue 3-4, 2004, Pages 391-399

  Kay, A Barry ^a   Larché, Mark ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergy; Asthma; Epitope; T cell; Tolerance

Indexed keywords

ALLERGEN; FELD CHAIN 1 PEPTIDE; IMMUNOGLOBULIN E; PEPTIDE; UNCLASSIFIED DRUG;

ALLERGY; ANAPHYLAXIS; ASTHMA; CAT; CLINICAL TRIAL; CYTOKINE RELEASE; DOSE RESPONSE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SCORING SYSTEM; SENSITIZATION; SIDE EFFECT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; CATS; CLINICAL TRIALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; PEPTIDES;

EID: 1442283559     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00281-003-0146-y     Document Type: Review

References (24)

1. Kay AB (2001) Allergy and allergic diseases. First of two parts. N Engl J Med 344:30-37
2. Kay AB (2001) Allergy and allergic diseases. Second of two parts. N Engl J Med 344:109-113
3. Noon L (1911) Prophylactic inoculation against hay fever. Lancet 1:1572-1573
4. Marsh DG, Norman PS, Roebber M, et al (1981) Studies on allergoids from naturally occurring allergens, III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 68:449-459
5. Ferreira F, Ebner C, Kramer B, et al (1998) Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 12:231-242
6. Creticos PS, Eiden JJ, Balcer S, et al (2000) Immunostimulatory oligonucleotides conjugated to Amb a 1: safety, skin test reactivity and basophil histamine release. J Allergy Clin Immunol 105:S70
7. Creticos PS, Balcer S, Schroeder JT, et al (2001) Initial immunotherapy trial to explore the safety, tolerability and immunogenicity of subcutaneous injections of an Amb a 1 immunostimulatory oligonucleotide conjugate (Aic) in ragweed allergic adults. J Allergy Clin Immunol 107:S216
8. Norman PS, Ohman JL, Long AA, et al (1996) Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 154:1623-1628
9. Pene J, Desroches A, Paradis L, et al (1998) Immunotherapy with Feld1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 102:571-578
10. Simons FE, Imada M, Li Y, et al (1996) Feld1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 8:1937-1945
11. Maguire P, Nicodemus C, Robinson D, et al (1999) The safety and efficacy of allervax cat in cat allergic patients. Clin Immunol 93:222-231
12. Oldfield WL, Kay AB, Larche M (2001) Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 167:1734-1739
13. Oldfield WL, Larche M, Kay AB (2002) Effect of T-cell peptides derived from Feld1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360 47-53
14. Muller U, Akdis CA, Fricker M, et al (1998) Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101:747-754
15. Fellrath JM, Kettner A, Dufour N, et al (2003) Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol 111:854-861
16. Haselden BM, Kay AB, Larche M (1999) Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 189:1885-1894
17. Vidard L, Colarusso LJ, Benacerraf B (1994) Specific T-cell tolerance may be preceded by a primary response. Proc Natl Acad Sci U S A 91:5627-5631
18. Webb S, Morris C, Sprent J (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-1256
19. Hoyne GF, Askonas BA, Hetzel C, et al (1996) Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 8:335-342
20. Marcotte GV, Braun CM, Norman PS, et al (1998) Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 101:506-513
21. Santambrogio L, Sato AK, Fischer FR, et al (1999) Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A 96:15050-15055
22. Santambrogio L, Sato AK, Carven GJ, et al (1999) Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci U S A 96:15056-15061
23. Hakonarson H, Maskeri N, Carter C, et al (1999) Regulation of TH1-and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J Clin Invest 103:1077-1087
24. Ati TR, Oldfield WLG, Higashi N, et al (2003) Late asthmatic reactions induced by inhalation of allergen-derived T-cell peptides. Am J Resp Crit Care Med DOI: 10.1164/rccm.200305-690C